Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Inhibikase Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.